‘Magic tables’ provide stimulation for memory care residents
By
Kimberly Bonvissuto
May 06, 2022
Table top gaming consoles — so-called magic tables — are taking off in memory care communities, providing an easy way to stimulate the brains of those with memory impairing diseases.
Medicare will only cover Aduhelm for patients in clinical trials
Apr 08, 2022
The decision is meant to protect patients while gathering more clinical data on whether the medication actually helps slow declines in thinking.
A high-fiber diet may reduce dementia risks later in life
By
John O'Connor
Apr 01, 2022
The mechanisms still remain unknown but could involve interactions taking place between the gut and brain.
Ventas riding senior housing recovery with occupancy, revenue growth
By
Kimberly Bonvissuto
Feb 22, 2022
The senior living industry pandemic recovery is underway with accelerating demand, strong rate increases and rapidly improving clinical conditions, with expectations for occupancy and revenue growth going...
Brookdale sees 10 months of occupancy growth, sets labor, occupancy goals for 2022
By
Lois A. Bowers
Feb 16, 2022
Entering 2022 having experienced 10 months of sequential weighted average occupancy growth, Brentwood, TN-based Brookdale Senior Living has identified strategies to improve occupancy further as well as...
Senior living resident-led program removes barriers to U.S. citizenship for workers
By
Kimberly Bonvissuto
Feb 11, 2022
When Rita Siebenaler found out that $725 was all that was standing between immigrant staff members at her life plan community and U.S. citizenship, she decided to do something about it.
Pressures mount for staffing agencies accused of price gouging long-term care operators
By
Kimberly Bonvissuto
Jan 31, 2022
While senior living and other long-term care leaders are being joined by other healthcare groups, and even members of Congress, to call for federal action against price-gouging by temporary staffing agencies,...
Should residents’ access to Alzheimer’s drug be restricted?
By
Lois A. Bowers
Jan 18, 2022
You have until Feb. 10 to share your comments with CMS about its recent proposal related to Alzheimer’s drug aducanumab (Aduhelm).
Positive company culture motivates, engages and retains employees, exec says
By
Kathleen Steele Gaivin
Jan 18, 2022
Survey after survey shows that money isn’t the prime motivator for healthcare employees anymore. Support and appreciation outweigh wages in retaining workers during the pandemic.
Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.